New Delhi: Hyderabad Biological Pharmaceutical Company E has requested permission from Indian drug regulators to conduct phase-3 clinical trials for Corbevax Vaccine Covid-19 as a dose of single booster for those who have been fully vaccinated with covishield or covaxin.
At present, the Corbevax 2/3 phase clinical trial, the RBD protein sub-unit vaccine will be given to adults, ongoing.
NOD is looking for a P-3 booster trial
